Osoresnontrine

DB16274InvestigationalSmall molecule

Osoresnontrine is under investigation in clinical trial NCT02281773 (A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12...

Mechanism: Pharmacologically active on High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A
Curator reviewed
Formula / weight: C₁₆H₁₇N₅O₂ · 311.345 g/mol (avg)
Code names: BI-409306 · SUB 166499

Resolves to

Compound

UNIIO9OC34WOAYCAS1189767-28-9ChEMBLCHEMBL4206492

Structure

InChIKeyBZTIJCSHNVZMES-UHFFFAOYSA-NSMILESO=C1NC(CC2=NC=CC=C2)=NC2=C1C=NN2C1CCOCC1

Targets

O76083PDE9A

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Osoresnontrine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account